Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
FOCUS trial
Description:
FOCUS is a clinical trial evaluating chemotherapy strategies for patients with advanced or metastatic colorectal cancer.
Related topics:
Colorectal Cancer Treatments and Studies (18%),
Stroke Rehabilitation and Recovery (14%),
Migraine and Headache Studies (11%),
Blood transfusion and management (9%)
OpenAlex ID:
keywords/focus-trial
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
2019
·
Michel D Ferrari
, Hans Christoph Diener
, et al.
·
The Lancet
·
454
Ranibizumab: Phase III clinical trial results.
2006
·
Philip J Rosenfeld
, Ryan M Rich
, et al.
·
PubMed
·
336
Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial
2014
·
Jeffrey L Carson
, Frederick Sieber
, et al.
·
The Lancet
·
225
Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder
2016
·
Roger S. McIntyre
, Ioana Florea
, et al.
·
The Journal of Clinical Psychiatry
·
105
Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review
2007
·
A L Takeda
, J Colquitt
, et al.
·
British Journal of Ophthalmology
·
101
Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia
2011
·
D. R. Rank
, H. D. Friedland
, et al.
·
Journal of Antimicrobial Chemotherapy
·
56
FOCUS phase 3 trial results: Percutaneous hepatic perfusion (PHP) with melphalan for patients with ocular melanoma liver metastases (PHP-OCM-301/301A).
2022
·
Jonathan S. Zager
, Marlana M. Orloff
, et al.
·
Journal of Clinical Oncology
·
53
Design and rationale of FOCUS (PX-171-011): A randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM)
2012
·
Roman Hájek
, Richard Bryce
, et al.
·
BMC Cancer
·
52
PDF
Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment in the phase 3b FOCUS study
2021
·
Messoud Ashina
, Joshua M. Cohen
, et al.
·
The Journal of Headache and Pain
·
49
PDF
Treatment of age-related macular degeneration: focus on ranibizumab
2008
·
Martin Spitzer
, Focke Ziemssen
, et al.
·
Clinical ophthalmology
·
48
PDF
Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities: The FOCUS Randomized Clinical Trial
2024
·
Hangyu Ji
, Xuefei Zhao
, et al.
·
JAMA Internal Medicine
·
46
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design
2010
·
James T. Willerson
, Emerson C. Perin
, et al.
·
American Heart Journal
·
45
Pre-morbid IQ and response to routine outcome assessment
2006
·
MIKE SLADE
, MORVEN LEESE
, et al.
·
Psychological Medicine
·
33
The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical and health economic analysis plan for the trials and for the individual patient data meta-analysis
2017
·
Catriona Graham
, Steff Lewis
, et al.
·
Trials
·
30
PDF
Cognitive–behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT
2019
·
Anthony P Morrison
, Melissa Pyle
, et al.
·
Health Technology Assessment
·
27
PDF
Day 4 Clinical Response of Ceftaroline Fosamil Versus Ceftriaxone for Community-Acquired Bacterial Pneumonia
2012
·
Paul B. Eckburg
, H. David Friedland
, et al.
·
Infectious Diseases in Clinical Practice
·
24
Effectiveness of cognitive remediation in the ultra‐high risk state for psychosis
2020
·
Louise B. Glenthøj
, Lise S. Mariegaard
, et al.
·
World Psychiatry
·
23
Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia
2016
·
Lesley J. Scott
·
Drugs
·
23
Assessment of Time to Clinical Response, a Proxy for Discharge Readiness, among Hospitalized Patients with Community-Acquired Pneumonia Who Received either Ceftaroline Fosamil or Ceftriaxone in Two Phase III FOCUS Trials
2014
·
Thomas P. Lodise
, Antonio R. Anzueto
, et al.
·
Antimicrobial Agents and Chemotherapy
·
23
PDF
Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer
2025
·
Lisa Paschold
, Christoph Schultheiss
, et al.
·
npj Precision Oncology
·
18
PDF
Daily fosfomycin versus levofloxacin for complicated urinary tract infections
2023
·
Nadine Rouphael
, Patricia Winokur
, et al.
·
mBio
·
18
Carfilzomib (K) Vs Low-Dose Corticosteroids and Optional Cyclophosphamide (Cy) in Patients (Pts) with Relapsed and Refractory Multiple Myeloma (Rrmm): Results from a Phase 3 Study (Focus)
2014
·
H. Ludwig
, T. Masszi
, et al.
·
Annals of Oncology
·
18
Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials
2013
·
Andrew F. Shorr
, Marin Kollef
, et al.
·
Diagnostic Microbiology and Infectious Disease
·
17
Estimation in multi-arm two-stage trials with treatment selection and time-to-event endpoint
2017
·
Matthias Brückner
, Andrew Titman
, et al.
·
Statistics in Medicine
·
16
PDF
Primary Tumour Location (Ptl) As a Prognostic and Predictive Factor in Advanced Colorectal Cancer (Acrc): Data from 2075 Patients (Pts) in Randomised Trials
2014
·
J.F. Seligmann
, F. Elliott
, et al.
·
Annals of Oncology
·
15
Show more works
View as search
Works count:
157
Citation count:
2,125
Year
Topic
Type